PortfoliosLab logoPortfoliosLab logo
AYTU vs. SIDU
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

AYTU vs. SIDU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Aytu BioPharma, Inc. (AYTU) and Sidus Space, Inc. (SIDU). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

AYTU vs. SIDU - Yearly Performance Comparison


2026 (YTD)20252024202320222021
AYTU
Aytu BioPharma, Inc.
1.54%52.94%-40.14%-24.87%-86.00%-19.16%
SIDU
Sidus Space, Inc.
-33.12%-35.92%-44.38%-91.92%-89.64%-13.70%

Fundamentals

Market Cap

AYTU:

$26.50M

SIDU:

$51.97M

EPS

AYTU:

-$2.02

SIDU:

-$1.30

PS Ratio

AYTU:

0.51

SIDU:

26.78

PB Ratio

AYTU:

1.87

SIDU:

1.03

Total Revenue (TTM)

AYTU:

$62.64M

SIDU:

$1.78M

Gross Profit (TTM)

AYTU:

$41.34M

SIDU:

-$5.69M

EBITDA (TTM)

AYTU:

-$17.24M

SIDU:

-$28.01M

Returns By Period

In the year-to-date period, AYTU achieves a 1.54% return, which is significantly higher than SIDU's -33.12% return.


AYTU

1D
-3.30%
1M
-0.00%
YTD
1.54%
6M
41.18%
1Y
127.59%
3Y*
5.63%
5Y*
-55.49%
10Y*

SIDU

1D
-9.48%
1M
3.45%
YTD
-33.12%
6M
92.66%
1Y
47.89%
3Y*
-66.35%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AYTU vs. SIDU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AYTU
AYTU Risk / Return Rank: 8585
Overall Rank
AYTU Sharpe Ratio Rank: 7575
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 9191
Sortino Ratio Rank
AYTU Omega Ratio Rank: 8989
Omega Ratio Rank
AYTU Calmar Ratio Rank: 8484
Calmar Ratio Rank
AYTU Martin Ratio Rank: 8484
Martin Ratio Rank

SIDU
SIDU Risk / Return Rank: 6262
Overall Rank
SIDU Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
SIDU Sortino Ratio Rank: 7676
Sortino Ratio Rank
SIDU Omega Ratio Rank: 7474
Omega Ratio Rank
SIDU Calmar Ratio Rank: 5555
Calmar Ratio Rank
SIDU Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AYTU vs. SIDU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Sidus Space, Inc. (SIDU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AYTUSIDUDifference

Sharpe ratio

Return per unit of total volatility

1.09

0.28

+0.81

Sortino ratio

Return per unit of downside risk

3.01

1.90

+1.11

Omega ratio

Gain probability vs. loss probability

1.39

1.25

+0.14

Calmar ratio

Return relative to maximum drawdown

2.83

0.61

+2.22

Martin ratio

Return relative to average drawdown

7.53

1.05

+6.48

AYTU vs. SIDU - Sharpe Ratio Comparison

The current AYTU Sharpe Ratio is 1.09, which is higher than the SIDU Sharpe Ratio of 0.28. The chart below compares the historical Sharpe Ratios of AYTU and SIDU, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


AYTUSIDUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.09

0.28

+0.81

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.65

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

-0.34

-0.02

Correlation

The correlation between AYTU and SIDU is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

AYTU vs. SIDU - Dividend Comparison

Neither AYTU nor SIDU has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

AYTU vs. SIDU - Drawdown Comparison

The maximum AYTU drawdown since its inception was -100.00%, roughly equal to the maximum SIDU drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for AYTU and SIDU.


Loading graphics...

Drawdown Indicators


AYTUSIDUDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-99.95%

-0.05%

Max Drawdown (1Y)

Largest decline over 1 year

-42.47%

-69.05%

+26.58%

Max Drawdown (5Y)

Largest decline over 5 years

-99.34%

Current Drawdown

Current decline from peak

-100.00%

-99.83%

-0.17%

Average Drawdown

Average peak-to-trough decline

-95.05%

-91.40%

-3.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.93%

39.73%

-23.80%

Volatility

AYTU vs. SIDU - Volatility Comparison

The current volatility for Aytu BioPharma, Inc. (AYTU) is 10.33%, while Sidus Space, Inc. (SIDU) has a volatility of 37.31%. This indicates that AYTU experiences smaller price fluctuations and is considered to be less risky than SIDU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


AYTUSIDUDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.33%

37.31%

-26.98%

Volatility (6M)

Calculated over the trailing 6-month period

38.47%

137.49%

-99.02%

Volatility (1Y)

Calculated over the trailing 1-year period

117.92%

173.88%

-55.96%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.84%

230.11%

-144.27%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

190.00%

230.11%

-40.11%

Financials

AYTU vs. SIDU - Financials Comparison

This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Sidus Space, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
15.17M
-1.02M
(AYTU) Total Revenue
(SIDU) Total Revenue
Values in USD except per share items